Colorectal Cancer
DYNAMIC trial data spark Twitter talk about ‘future of patient risk stratification’
The potential for ctDNA-guided management to reduce adjuvant chemotherapy by half without compromising recurrence-free survival sparked interest on social media after a presentation at the ASCO Annual Meeting.
Panitumumab regimen new first-line standard in RAS wild-type metastatic colorectal cancer
CHICAGO — The addition of panitumumab vs. bevacizumab to standard doublet chemotherapy significantly extended survival among patients with RAS wild-type and left-sided metastatic colorectal cancer, according to study results.
Top in hem/onc: Microaggressions in the workplace; height-related cancer risk
An education session at the ASCO Annual Meeting will review strategies to address bias and microaggressions in the medical workplace.
Late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic
The percentage of patients presenting with late-stage breast and colorectal cancers increased between 2019 and 2020 at Moores Cancer Center at University of California San Diego Health, according to data published in JAMA Network Open.
Alcohol intake significantly influences colorectal cancer risk
High alcohol consumption was significantly associated with an increased risk for colorectal cancer, regardless of genetic risk, according to findings published in The Lancet’s eClinical Medicine.
Taller adults may have higher risk for colorectal cancer, adenoma
Greater adult-attained height correlated with increased risk for colorectal cancer and adenoma, according to a meta-analysis published in Cancer, Epidemiology, Biomarkers & Prevention.
Voice assistants should offer users ‘more thorough’ information on CRC screening
SAN DIEGO — A pilot study presented at Digestive Disease Week 2022 demonstrated that while voice assistants performed well in providing clinically accurate information on colorectal cancer screening, improvements are still needed.
Advanced outreach campaign improves CRC screening rates
SAN DIEGO — Pre-alert text message notification followed by mailed fecal immunochemical test kits improved population-level screening for colorectal cancer during COVID-19, according to research.
Lifetime excess weight linked to colorectal cancer risk
Excess weight had a stronger impact on colorectal cancer risk than suggested in previous studies that did not consider cumulative lifetime exposure, according to a study published in JAMA Oncology.
VIDEO: Virtual platforms may boost enrollment, encourage diversity in clinical trials
In this video exclusive, Aasma Shaukat, MD, MPH, professor at NYU Grossman School of Medicine, discusses how her group achieved diverse enrollment for PREEMPT CRC, a study designed to validate a blood test for colorectal cancer screening.